US Stock MarketDetailed Quotes

COYA Coya Therapeutics

Watchlist
  • 5.740
  • +0.050+0.88%
Trading May 15 10:11 ET
96.00MMarket Cap-5.36P/E (TTM)

Coya Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
8.04%-10.29M
-7.53%-2.41M
-146.44%-5.46M
-59.13%-4.56M
155.54%2.15M
-54.56%-11.19M
-0.81%-2.24M
-39.24%-2.22M
-99.15%-2.87M
-94.68%-3.86M
Net income from continuing operations
-86.29%-14.88M
-330.32%-2.92M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
Operating gains losses
----
----
----
----
--25K
----
----
----
----
----
Depreciation and amortization
0.00%27.36K
0.00%6.84K
0.00%6.84K
0.00%6.84K
0.00%6.84K
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
Other non cash items
-95.40%25K
--0
--0
----
----
-86.48%543.19K
-87.21%193.19K
--0
----
----
Change In working capital
140.40%1.88M
92.61%-291.38K
-337.30%-2.22M
-630.50%-2.34M
612.01%6.73M
-717.66%-4.64M
-460.26%-3.95M
15.07%936.27K
-133.76%-320.47K
-328.50%-1.31M
-Change in receivables
200.00%7.5M
--0
--0
--0
--7.5M
---7.5M
---7.5M
--0
--0
--0
-Change in prepaid assets
-2,796.16%-4.9M
-1,040.86%-1.52M
-424.28%-1.14M
-614.39%-1.97M
-215.09%-275.4K
119.75%181.71K
88.86%-133.2K
388.69%350.86K
-2,233.67%-275.24K
25.08%239.3K
-Change in payables and accrued expense
-186.75%-1.02M
-43.83%1.23M
-285.18%-1.08M
-1,667.69%-799.48K
76.35%-367.48K
-29.61%1.18M
345.32%2.19M
-21.08%585.41K
-104.83%-45.23K
-211.95%-1.55M
-Change in other working capital
-80.24%295.94K
---1.95K
--0
--424.73K
---126.84K
--1.5M
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
8.04%-10.29M
-7.53%-2.41M
-146.44%-5.46M
-59.13%-4.56M
155.54%2.15M
-54.56%-11.19M
-0.81%-2.24M
-39.24%-2.22M
-99.15%-2.87M
-94.68%-3.86M
Investing cash flow
Cash flow from continuing investing activities
95.40%-25K
0
0
0
-25K
-3.46%-543.19K
50.47%-193.19K
0
-350K
0
Net intangibles purchase and sale
----
----
--0
--0
---25K
----
----
--0
---350K
--0
Net other investing changes
95.40%-25K
----
----
----
----
-3.46%-543.19K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
95.40%-25K
--0
--0
--0
---25K
-3.46%-543.19K
50.47%-193.19K
--0
---350K
--0
Financing cash flow
Cash flow from continuing financing activities
-58.29%16.03M
-59.91%9.69M
-56.33K
5.15M
-91.29%1.24M
310.62%38.43M
23,329.10%24.17M
0
0
21,947.26%14.25M
Net common stock issuance
-63.47%14M
-62.38%9.06M
---56.33K
--5M
--0
--38.34M
--24.08M
--0
--0
--14.25M
Proceeds from stock option exercised by employees
2,282.63%2.14M
601.99%631.42K
--0
--149.25K
--1.36M
56,828.48%89.95K
--89.95K
--0
--0
--0
Net other financing activities
---120.67K
--0
--0
--0
---120.67K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-58.29%16.03M
-59.91%9.69M
---56.33K
--5.15M
-91.29%1.24M
310.62%38.43M
23,329.10%24.17M
--0
--0
21,947.26%14.25M
Net cash flow
Beginning cash position
449.86%32.63M
185.29%31.06M
179.15%36.58M
120.52%35.99M
449.86%32.63M
36.72%5.93M
25.84%10.89M
26.14%13.1M
612.59%16.32M
36.72%5.93M
Current changes in cash
-78.60%5.71M
-66.50%7.28M
-148.98%-5.52M
118.20%585.68K
-67.63%3.36M
1,575.10%26.69M
900.12%21.74M
-27.63%-2.22M
-139.74%-3.22M
606.68%10.39M
End cash Position
17.51%38.34M
17.51%38.34M
185.29%31.06M
179.15%36.58M
120.52%35.99M
449.86%32.63M
449.86%32.63M
25.84%10.89M
26.14%13.1M
612.59%16.32M
Free cash flow
8.04%-10.29M
-26.11%-2.38M
-146.44%-5.46M
-41.82%-4.56M
154.89%2.12M
-54.56%-11.19M
9.43%-1.89M
-28.36%-2.22M
-123.46%-3.22M
-94.68%-3.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 8.04%-10.29M-7.53%-2.41M-146.44%-5.46M-59.13%-4.56M155.54%2.15M-54.56%-11.19M-0.81%-2.24M-39.24%-2.22M-99.15%-2.87M-94.68%-3.86M
Net income from continuing operations -86.29%-14.88M-330.32%-2.92M-17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M
Operating gains losses ------------------25K--------------------
Depreciation and amortization 0.00%27.36K0.00%6.84K0.00%6.84K0.00%6.84K0.00%6.84K0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K
Other non cash items -95.40%25K--0--0---------86.48%543.19K-87.21%193.19K--0--------
Change In working capital 140.40%1.88M92.61%-291.38K-337.30%-2.22M-630.50%-2.34M612.01%6.73M-717.66%-4.64M-460.26%-3.95M15.07%936.27K-133.76%-320.47K-328.50%-1.31M
-Change in receivables 200.00%7.5M--0--0--0--7.5M---7.5M---7.5M--0--0--0
-Change in prepaid assets -2,796.16%-4.9M-1,040.86%-1.52M-424.28%-1.14M-614.39%-1.97M-215.09%-275.4K119.75%181.71K88.86%-133.2K388.69%350.86K-2,233.67%-275.24K25.08%239.3K
-Change in payables and accrued expense -186.75%-1.02M-43.83%1.23M-285.18%-1.08M-1,667.69%-799.48K76.35%-367.48K-29.61%1.18M345.32%2.19M-21.08%585.41K-104.83%-45.23K-211.95%-1.55M
-Change in other working capital -80.24%295.94K---1.95K--0--424.73K---126.84K--1.5M----------------
Cash from discontinued investing activities
Operating cash flow 8.04%-10.29M-7.53%-2.41M-146.44%-5.46M-59.13%-4.56M155.54%2.15M-54.56%-11.19M-0.81%-2.24M-39.24%-2.22M-99.15%-2.87M-94.68%-3.86M
Investing cash flow
Cash flow from continuing investing activities 95.40%-25K000-25K-3.46%-543.19K50.47%-193.19K0-350K0
Net intangibles purchase and sale ----------0--0---25K----------0---350K--0
Net other investing changes 95.40%-25K-----------------3.46%-543.19K----------------
Cash from discontinued investing activities
Investing cash flow 95.40%-25K--0--0--0---25K-3.46%-543.19K50.47%-193.19K--0---350K--0
Financing cash flow
Cash flow from continuing financing activities -58.29%16.03M-59.91%9.69M-56.33K5.15M-91.29%1.24M310.62%38.43M23,329.10%24.17M0021,947.26%14.25M
Net common stock issuance -63.47%14M-62.38%9.06M---56.33K--5M--0--38.34M--24.08M--0--0--14.25M
Proceeds from stock option exercised by employees 2,282.63%2.14M601.99%631.42K--0--149.25K--1.36M56,828.48%89.95K--89.95K--0--0--0
Net other financing activities ---120.67K--0--0--0---120.67K--------------------
Cash from discontinued financing activities
Financing cash flow -58.29%16.03M-59.91%9.69M---56.33K--5.15M-91.29%1.24M310.62%38.43M23,329.10%24.17M--0--021,947.26%14.25M
Net cash flow
Beginning cash position 449.86%32.63M185.29%31.06M179.15%36.58M120.52%35.99M449.86%32.63M36.72%5.93M25.84%10.89M26.14%13.1M612.59%16.32M36.72%5.93M
Current changes in cash -78.60%5.71M-66.50%7.28M-148.98%-5.52M118.20%585.68K-67.63%3.36M1,575.10%26.69M900.12%21.74M-27.63%-2.22M-139.74%-3.22M606.68%10.39M
End cash Position 17.51%38.34M17.51%38.34M185.29%31.06M179.15%36.58M120.52%35.99M449.86%32.63M449.86%32.63M25.84%10.89M26.14%13.1M612.59%16.32M
Free cash flow 8.04%-10.29M-26.11%-2.38M-146.44%-5.46M-41.82%-4.56M154.89%2.12M-54.56%-11.19M9.43%-1.89M-28.36%-2.22M-123.46%-3.22M-94.68%-3.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Adobe
ADBE
401.150
Vale SA
VALE
9.815
Microsoft
MSFT
452.835
4
Salesforce
CRM
290.925
5
Lennar Corp
LEN
108.300
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.